Related Experiment Videos
Circulating tumor markers in gynecological tumors
1Center for Cancer Treatment, Mount Vernon Hospital, Northwood, Middlesex, UK.
Current Opinion in Oncology
|September 1, 1996
Summary
Tumor markers aid gynecological cancer management, offering prognostic insights for early ovarian and cervical cancers. Their primary role is monitoring treatment response and detecting relapse, potentially outperforming imaging scans.
Area of Science:
- Gynecologic Oncology
- Clinical Chemistry
- Cancer Biomarkers
Background:
- Tumor markers play a role in managing gynecological cancers.
- Their utility varies across different cancer types and clinical applications.
Purpose of the Study:
- To evaluate the impact and appropriate use of tumor markers in gynecological cancer management.
- To assess the role of tumor markers in screening, prognosis, and monitoring of ovarian and cervical cancers.
Main Methods:
- Review of current literature and clinical guidelines on tumor marker usage in gynecological oncology.
- Analysis of the diagnostic and prognostic value of specific tumor markers.
Main Results:
- Tumor markers are not recommended for ovarian cancer screening outside clinical trials.
- Elevated marker levels provide prognostic information influencing therapy for early ovarian and cervical cancers.
- Tumor markers are highly valuable for monitoring treatment response and confirming relapse, potentially exceeding imaging sensitivity.
Conclusions:
- Judicious use of tumor markers significantly impacts gynecological cancer management.
- Tumor markers are crucial for prognostication and post-treatment surveillance.
- Their role in monitoring therapy response and relapse detection is a key clinical application.